Joshi Anita, Deshpande Smita, Dohe Vaishali, Risbud Shilpa, Bharadwaj Renu
Deperatment of Microbiology B. J. Medical College, Pune.
Hindustan Antibiot Bull. 2007;49-50(1-4):10-3.
A new polyenzyme formulation 'Candidaseb' was tested for its ability to inhibit clinically important fungi. After its antifungal activity was established, an assay was standardized to determine whether any potentiation effect was possible if Candidaseb was used in conjunction with three standard antifungal agents viz, Amphotericin B, Miconazole and Ketoconazole against 5 clinically significant fungi viz., Candida albicans, Cryptococcus neoformans, Aspergillusniger, Microsporum gypseum and Trichophyton rubrum. A synergistic effect could be established when a combination of Candidaseb and antifungal was used against all 5 pathogenic fungi. A reduction in MIC values of standard drugs could be observed. Also, Miconazole, which had proved ineffective against Candida and Cryptococcus became effective when it was used in combination with Candidaseb indicating a potentiating effect on the drug.
一种新的多酶制剂“Candidaseb”被测试了其抑制临床上重要真菌的能力。在确定其抗真菌活性后,进行了一项试验标准化,以确定如果将Candidaseb与三种标准抗真菌药物(即两性霉素B、咪康唑和酮康唑)联合使用,对5种临床上具有重要意义的真菌(即白色念珠菌、新型隐球菌、黑曲霉、石膏样小孢子菌和红色毛癣菌)是否可能有增效作用。当Candidaseb与抗真菌药物联合用于所有5种致病真菌时,可以确定有协同作用。可以观察到标准药物的最低抑菌浓度值降低。此外,已证明对念珠菌和隐球菌无效的咪康唑,当与Candidaseb联合使用时变得有效,表明对该药物有增效作用。